CGVHD
Clinical trials for CGVHD explained in plain language.
Never miss a new study
Get alerted when new CGVHD trials appear
Sign up with your email to follow new studies for CGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for transplant patients: experimental drug targets stubborn GVHD
Disease control Not yet recruitingThis early-stage study tests whether the drug sarilumab can safely help adults with chronic graft-versus-host disease (cGVHD) that has not improved with the standard treatment belumosudil. cGVHD is a complication after a stem cell transplant where the donor cells attack the patie…
Matched conditions: CGVHD
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 26, 2026 08:57 UTC
-
New hope for transplant patients with stubborn immune attack
Disease control Not yet recruitingThis study tests a drug called gecacitinib in 33 adults who have chronic graft-versus-host disease (cGVHD) after a stem cell transplant and whose condition did not improve with steroids. The goal is to see if the drug can safely control the disease and reduce symptoms. Participan…
Matched conditions: CGVHD
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 08:32 UTC